PD3-3-4: Vandetanib in advanced NSCLC: an ongoing clinical evaluation program
نویسندگان
چکیده
منابع مشابه
A randomized double-blind Phase IIa dose-finding study of vandetanib in Japanese patients with NSCLC: PD3-3-2
Copyright © 2007 by the International Association for the Study of Lung Cancer S466 Materials and Methods: Enrollees received Cb AUC 6 day 1 in combination with Pac 100 mg/m2 days 1, 8, and 15 every 4 weeks, and C225 at a loading dose of 400 mg/m2 day 1, then 250 mg/m2 weekly thereafter. C225 was continued as a single agent after 6 full cycles of therapy in patients without disease progression ...
متن کاملProgram evaluation: an ongoing systematic process.
The time immediately following an accreditation visit is ideal to reevaluate and update the plan for ongoing systematic program evaluation. This article demonstrates how use of an evaluation framework, existing nursing program resources, data, and a timeline can be integral to an ongoing program evaluation plan. Guidelines provided by the accrediting body can be the template for the evaluation ...
متن کاملPrognostic Significance of 14-3-3γ Overexpression in Advanced NSCLC
Lung cancer is the most frequently diagnosed cancer and the leading cause of cancer death in males globally (Jemal et al., 2011). Approximately 85% of lung cancer cases are non-small cell carcinoma (NSCLC) (Herbst et al., 2008). Most lung cancer patients are of advanced stage at the time of diagnosis, resulting in a poor outcome with 5-year relative survival being less than 14% (Youlden et al.,...
متن کاملPemetrexed in advanced NSCLC: a review of the clinical data.
The novel multitargeted antimetabolite pemetrexed (Alimta), recently approved by the US Food and Drug Administration for the treatment of mesothelioma when combined with cisplatin, is also active in first- and second-line non-small-cell lung cancer (NSCLC). In a phase III trial comparing single-agent pemetrexed vs docetaxel (Taxotere) as second-line therapy in advanced NSCLC, survival was shown...
متن کاملAn indecomposable PD3-complex : II
We show that there are two homotopy types of PD3 -complexes with fundamental group S3 ∗Z/2Z S3 , and give explicit constructions for each, which differ only in the attachment of the top cell. AMS Classification 57P10; 55M05
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thoracic Oncology
سال: 2007
ISSN: 1556-0864
DOI: 10.1097/01.jto.0000283414.23120.66